1. Psychoneurological symptom cluster in breast cancer: the role of inflammation and diet

   • Mridula A. George
   • Maryam B. Lustberg
   • Tonya S. Orchard

   Review 15 August 2020 Pages: 1 - 9

   

2. Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors

   • Chaiwat Aphivatanasiri
   • Joshua Li
   • Gary M. Tse

   Preclinical study 01 August 2020 Pages: 11 - 21

   

3. Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials

   • Richard S. Finn
   • Massimo Cristofanilli
   • Hope S. Rugo

   Clinical trial Open access 11 August 2020 Pages: 23 - 35

   

4. Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance

   • W. B. G. Sanderink
   • L. J. A. Strobbe
   • R. M. Mann

   Clinical trial Open access 01 August 2020 Pages: 37 - 43

   

5. Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

   • Therse Björkin Joona
   • Evangelos Digkas
   • Antonis Valachis

   Clinical trial Open access 01 August 2020 Pages: 45 - 52

   

6. Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer

   • Jennifer R. Diamond
   • Carlos Becerra
   • Monica Mita

   Clinical trial 14 August 2020 Pages: 53 - 62

   

7. Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients

   • Jessica S. Crystal
   • Jamie Rand
   • Alice Chung

   Clinical trial 09 August 2020 Pages: 63 - 74

   

8. Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy

   • Amy A. Kirkham
   • Sean A. Virani
   • Kristin L. Campbell

   Clinical trial 20 August 2020 Pages: 75 - 85

   

9. Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

   • Yada Kanjanapan
   • Sheau Wen Lok
   • Laeeq Malik

   Clinical trial 10 August 2020 Pages: 87 - 95

   

10. Shoulder amplitude movement does not influence postoperative wound complications after breast cancer surgery: a randomized clinical trial

    • Clarice Gomes Chagas Teodózio
    • Liz de Oliveira Marchito
    • Anke Bergmann

    Clinical trial 17 August 2020 Pages: 97 - 105

    

11. Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen

    • C. Louwrens Braal
    • Koen G. A. M. Hussaarts
    • Ron H. J. Mathijssen

    Clinical Trial Open access 16 August 2020 Pages: 107 - 113

    

12. Should we be talking about guidelines with patients? A qualitative analysis in metastatic breast cancer

    • Olivia Hull
    • Soumya J. Niranjan
    • Gabrielle B. Rocque

    Clinical trial 31 July 2020 Pages: 115 - 121

    

13. Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients

    • Signe Korsgaard Skriver
    • Maj-Britt Jensen
    • Anne-Vibeke Laenkholm

    Clinical trial 03 August 2020 Pages: 123 - 133

    

14. 57% decline in Rhode Island invasive breast cancer mortality between 1987 and 2017: mammography predominates in preventing mortality

    • Blake Cady
    • John P. Fulton

    Clinical trial 10 August 2020 Pages: 135 - 147

    

15. Impact of breast cancer subtype on clinical outcomes after Gamma Knife radiosurgery for brain metastases from breast cancer: a multi-institutional retrospective study (JLGK1702)

    • Kyoko Aoyagi
    • Yoshinori Higuchi
    • Yasuo Iwadate

    Clinical trial 01 August 2020 Pages: 149 - 159

    

16. Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

    • Hope S. Rugo
    • Veronique Dieras
    • Sara M. Tolaney

    Clinical trial Open access 12 August 2020 Pages: 161 - 172

    

17. Outcomes following lymphaticovenous anastomosis (LVA) for 100 cases of lymphedema: results over 24-months follow-up

    • Shan S. Qiu
    • Tim Pruimboom
    • René R. W. J. van der Hulst

    Clinical trial Open access 07 August 2020 Pages: 173 - 183

    

18. Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models

    • Leah H. Portnow
    • Ellie Kwak
    • Catherine S. Giess

    Clinical trial 08 August 2020 Pages: 185 - 192

    

19. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis

    • Weiqi Gao
    • Yufei Zeng
    • Kunwei Shen

    Clinical trial 01 August 2020 Pages: 193 - 202

    

20. Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study

    • Michael Zeidman
    • J. Jaime Alberty-Oller
    • Hank Schmidt

    Epidemiology 01 August 2020 Pages: 203 - 212

21. The impact of selected risk factors among breast cancer molecular subtypes: a case-only study

    • Margherita Pizzato
    • Greta Carioli
    • Carlo La Vecchia

    Epidemiology 26 August 2020 Pages: 213 - 220

22. Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018

    • Jenny Nyqvist
    • Toshima Z. Parris
    • Anikó Kovács

    Epidemiology Open access 01 August 2020 Pages: 221 - 228

    

23. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients

    • Anna P. Sokolenko
    • Tatiana N. Sokolova
    • Evgeny N. Imyanitov

    Epidemiology 09 August 2020 Pages: 229 - 235

24. Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity

    • Yan-Ting Zhou
    • Li-Yuan Zheng
    • Wei-Gang Fang

    Epidemiology 05 August 2020 Pages: 237 - 248

    

25. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

    • Elizabeth Lerner Papautsky
    • Tamara Hamlish

    Brief Report 09 August 2020 Pages: 249 - 254